1,258 research outputs found
Report on the selection of the reference XT-ADS target design and specifications
The XT-ADS is an experimental accelerator driven system (ADS) that is being developed in the framework of the European FP6 EUROTRANS project. In this deliverable, the specifications of the spallation target and the selection of its reference design are discussed. Justification of the design options, in relation to the performance requirements of the XT-ADS and the interlinking with the design of the sub-critical core and the primary system, are given
Bridging the Gap: Improving the relationship between social service organizations and healthcare providers
In Vermont, a significant social determinant of health is rurality. Barriers to healthcare services include distance to providers, lack of integration with social services, and failure to recognize community needs.
Integration and robust collaboration between healthcare and social services can likely improve outcomes for individuals who have high utilization of both categories of services.
Understanding relationships between healthcare and social services may provide an important framework for translating interventional research to rural communities to improve health equity.
Project Goal: To understand barriers affecting collaboration between social service providers and community health providers in order to promote research-based improvements in health outcomes in rural populations.https://scholarworks.uvm.edu/comphp_gallery/1314/thumbnail.jp
Structure of the human mTOR Complex I and its implications for rapamycin inhibition
The mammalian target of rapamycin complex 1 (mTORC1) regulates cell growth in response to the nutrient and energy status of the cell, and its deregulation is common in human cancers. Little is known about the overall architecture and subunit organization of this essential signaling complex. We have determined the three-dimensional (3D) structure of the fully assembled human mTORC1 by cryo-electron microscopy (cryo-EM). Our analyses reveal that mTORC1 is an obligate dimer with an overall rhomboid shape and a central cavity. The dimeric interfaces are formed by interlocking interactions between the mTOR and raptor subunits. Extended incubation with FKBP12-rapamycin compromises the structural integrity of mTORC1 in a stepwise manner, leading us to propose a model in which rapamycin inhibits mTORC1-mediated phosphorylation of 4E-BP1 and S6K1 through different mechanisms.National Institutes of Health (U.S.) (Grant AI47389)National Institutes of Health (U.S.) (Grant CA103866)United States. Dept. of Defense (W81XWH-07-1-0448)W. M. Keck Foundatio
Systemic insulin sensitivity is regulated by GPS2 inhibition of AKT ubiquitination and activation in adipose tissue
OBJECTIVE: Insulin signaling plays a unique role in the regulation of energy homeostasis and the impairment of insulin action is associated with altered lipid metabolism, obesity, and Type 2 Diabetes. The main aim of this study was to provide further insight into the regulatory mechanisms governing the insulin signaling pathway by investigating the role of non-proteolytic ubiquitination in insulin-mediated activation of AKT.
METHODS: The molecular mechanism of AKT regulation through ubiquitination is first dissected in vitro in 3T3-L1 preadipocytes and then validated in vivo using mice with adipo-specific deletion of GPS2, an endogenous inhibitor of Ubc13 activity (GPS2-AKO mice).
RESULTS: Our results indicate that K63 ubiquitination is a critical component of AKT activation in the insulin signaling pathway and that counter-regulation of this step is provided by GPS2 preventing AKT ubiquitination through inhibition of Ubc13 enzymatic activity. Removal of this negative checkpoint, through GPS2 downregulation or genetic deletion, results in sustained activation of insulin signaling both in vitro and in vivo. As a result, the balance between lipid accumulation and utilization is shifted toward storage in the adipose tissue and GPS2-AKO mice become obese under normal laboratory chow diet. However, the adipose tissue of GPS2-AKO mice is not inflamed, the levels of circulating adiponectin are elevated, and systemic insulin sensitivity is overall improved.
CONCLUSIONS: Our findings characterize a novel layer of regulation of the insulin signaling pathway based on non-proteolytic ubiquitination of AKT and define GPS2 as a previously unrecognized component of the insulin signaling cascade. In accordance with this role, we have shown that GPS2 presence in adipocytes modulates systemic metabolism by restricting the activation of insulin signaling during the fasted state, whereas in absence of GPS2, the adipose tissue is more efficient at lipid storage, and obesity becomes uncoupled from inflammation and insulin resistance
mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis
mTORC2 phosphorylates AKT in a hydrophobic motif site that is a biomarker of insulin sensitivity. In brown adipocytes, mTORC2 regulates glucose and lipid metabolism, however the mechanism has been unclear because downstream AKT signaling appears unaffected by mTORC2 loss. Here, by applying immunoblotting, targeted phosphoproteomics and metabolite profiling, we identify ATP-citrate lyase (ACLY) as a distinctly mTORC2-sensitive AKT substrate in brown preadipocytes. mTORC2 appears dispensable for most other AKT actions examined, indicating a previously unappreciated selectivity in mTORC2-AKT signaling. Rescue experiments suggest brown preadipocytes require the mTORC2/AKT/ACLY pathway to induce PPAR-gamma and establish the epigenetic landscape during differentiation. Evidence in mature brown adipocytes also suggests mTORC2 acts through ACLY to increase carbohydrate response element binding protein (ChREBP) activity, histone acetylation, and gluco-lipogenic gene expression. Substrate utilization studies additionally implicate mTORC2 in promoting acetyl-CoA synthesis from acetate through acetyl-CoA synthetase 2 (ACSS2). These data suggest that a principal mTORC2 action is controlling nuclear-cytoplasmic acetyl-CoA synthesis
Destruction of the Mott Insulating Ground State of Ca_2RuO_4 by a Structural Transition
We report a first-order phase transition at T_M=357 K in single crystal
Ca_2RuO_4, an isomorph to the superconductor Sr_2RuO_4. The discontinuous
decrease in electrical resistivity signals the near destruction of the Mott
insulating phase and is triggered by a structural transition from the low
temperature orthorhombic to a high temperature tetragonal phase. The magnetic
susceptibility, which is temperature dependent but not Curie-like decreases
abruptly at TM and becomes less temperature dependent. Unlike most insulator to
metal transitions, the system is not magnetically ordered in either phase,
though the Mott insulator phase is antiferromagnetic below T_N=110 K.Comment: Accepted for publication in Phys. Rev. B (Rapid Communications
Nucleon-induced reactions at intermediate energies: New data at 96 MeV and theoretical status
Double-differential cross sections for light charged particle production (up
to A=4) were measured in 96 MeV neutron-induced reactions, at TSL laboratory
cyclotron in Uppsala (Sweden). Measurements for three targets, Fe, Pb, and U,
were performed using two independent devices, SCANDAL and MEDLEY. The data were
recorded with low energy thresholds and for a wide angular range (20-160
degrees). The normalization procedure used to extract the cross sections is
based on the np elastic scattering reaction that we measured and for which we
present experimental results. A good control of the systematic uncertainties
affecting the results is achieved. Calculations using the exciton model are
reported. Two different theoretical approches proposed to improve its
predictive power regarding the complex particle emission are tested. The
capabilities of each approach is illustrated by comparison with the 96 MeV data
that we measured, and with other experimental results available in the
literature.Comment: 21 pages, 28 figure
The Combination of RAD001 and NVP-BEZ235 Exerts Synergistic Anticancer Activity against Non-Small Cell Lung Cancer In Vitro and In Vivo
The phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) signaling axis has emerged as a novel target for cancer therapy. Agents that inhibit PI3K, mTOR or both are currently under development. The mTOR allosteric inhibitor, RAD001, and the PI3K/mTOR dual kinase inhibitor, BEZ235, are examples of these agents. We were interested in developing strategies to enhance mTOR-targeted caner therapy. In this study, we found that BEZ235 alone effectively inhibited the growth of rapamycin-resistant cancer cells. Interestingly, the combination of sub-optimal concentrations of RAD001 and BEZ235 exerted synergistic inhibition of the growth of human lung cancer cells along with induction of apoptosis and G1 arrest. Furthermore, the combination was also more effective than either agent alone in inhibiting the growth of lung cancer xenografts in mice. The combination showed enhanced effects on inhibiting mTOR signaling and reducing the expression of c-Myc and cyclin D1. Taken together, our results suggest that the combination of RAD001 and BEZ235 is a novel strategy for cancer therapy
The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development
Overweight and obesity are associated with type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease and cancer, but all fat is not equal, as storing excess lipid in subcutaneous white adipose tissue (SWAT) is more metabolically favorable than in visceral fat. Here, we uncover a critical role for mTORC2 in setting SWAT lipid handling capacity. We find that subcutaneous white preadipocytes differentiating without the essential mTORC2 subunit Rictor upregulate mature adipocyte markers but develop a striking lipid storage defect resulting in smaller adipocytes, reduced tissue size, lipid re-distribution to visceral and brown fat, and sex-distinct effects on systemic metabolic fitness. Mechanistically, mTORC2 promotes transcriptional upregulation of select lipid metabolism genes controlled by PPARÎł and ChREBP, including genes that control lipid uptake, synthesis, and degradation pathways as well as Akt2, which encodes a major mTORC2 substrate and insulin effector. Further exploring this pathway may uncover new strategies to improve insulin sensitivity.Fil: Hsiao, Wen Yu. University Of Massachussets. Medical School; Estados UnidosFil: Jung, Su Myung. University Of Massachussets. Medical School; Estados UnidosFil: Tang, Yuefeng. University Of Massachussets. Medical School; Estados UnidosFil: Haley, John A.. University Of Massachussets. Medical School; Estados UnidosFil: Li, Rui. University Of Massachussets. Medical School; Estados UnidosFil: Li, Huawei. University Of Massachussets. Medical School; Estados UnidosFil: Martinez Calejman, Camila. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Centro de Estudios FarmacolĂłgicos y Botánicos. Universidad de Buenos Aires. Facultad de Medicina. Centro de Estudios FarmacolĂłgicos y Botánicos; Argentina. University Of Massachussets. Medical School; Estados UnidosFil: Sanchez Gurmaches, Joan. University Of Massachussets. Medical School; Estados Unidos. University of Cincinnati; Estados UnidosFil: Hung, Chien-Min. University Of Massachussets. Medical School; Estados UnidosFil: Luciano, Amelia K.. University Of Massachussets. Medical School; Estados UnidosFil: DeMambro, Victoria. University of Maine; Estados UnidosFil: Wellen, Kathryn E.. University of Pennsylvania; Estados UnidosFil: Rosen, Clifford J.. University of Maine; Estados UnidosFil: Zhu, Lihua Julie. University Of Massachussets. Medical School; Estados UnidosFil: Guertin, David A.. University Of Massachussets. Medical School; Estados Unido
- …